the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 
RSS Feed
Medical Device
Disposable Medical Device
Orthopedic
Endoscopy Equipment
Catheter Equipment
Dental Equipment
Ophthalmic Equipment
Patient Monitoring
Cardiovascular Control Equipment
Healthcare IT
Medical Imaging
CT and MRI and X ray
Nuclear Medical
Ultra Sound
Molecular Imaging/Agents
Wound Care
In Vitro Diagnostics Equipment

* View All Categories
View Conferences
Japanese Korean Chinese
Home > Category > Medical Devices >

Market Research Report

Products, Technologies, Markets and Opportunities in Ophthalmology Surgical, Device and Drug Markets Worldwide, 2007

Published by MedMarket Diligence Contact us : +1-860-674-8796
Published 2006/11 Content info 330 pages · 201 Exhibits · 105 Company Profiles
Product code MED45836
Price From  US $ 2450 Order/Price list
US $ 2450 Hard Copy
US $ 2450 PDF by E-mail (Single User License)
US $ 2650 PDF by E-mail (Single User License) & Hard Copy
US $ 3950 PDF by E-mail (Site License)
US $ 4950 PDF by E-mail (Global License)
How to Order?
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Table of Contents

EXECUTIVE SUMMARY

Ophthalmology Background & Market Segments

  • Vision Diagnostics
  • Eye Care Products
  • Cataract Surgery
  • Refractive Surgery
  • Glaucoma
  • Back of Eye

The Ophthalmology Pharmaceutical Market

The Ophthalmic Device Market

Section 1: About vision care

  • 1.1 The Eye Care Specialist: Optometrists & Ophthalmologists
  • 1.2 Diagnostic Map for Ocular Conditions
  • 1.3 Diseases of the Eye and Vision Conditions
    • 1.3.1 Conditions of the Cornea
    • 1.3.2 Cornea Disease Diagnostics
      • 1.3.2.1 Visual Acuity and General Vision Diagnostics
    • 1.3.3 Glaucoma
      • 1.3.3.1 Glaucoma Diagnostics
    • 1.3.4 Cataracts
      • 1.3.4.1 Cataract Diagnostics
    • 1.3.5 Back of Eye Disorders
      • 1.3.5.1 Retinal Diagnostics

Section 2: THE MARKET FOR DIAGNOSTIC INSTRUMENTATION

  • 2.1 Market Overview: Diagnostic Devices
    • 2.1.1 Hand-held Instruments
    • 2.1.2 Diagnostic Equipment

Section 3: THERAPEUTIC OPTIONS

  • 3.1 Vision Correction Options
    • 3.1.1 Corrective Lenses
      • 3.1.1.1 Eyeglasses--The Old Standby
    • 3.1.2 Contact Lenses
    • 3.1.3 Orthokeratology
    • 3.1.4 Corneal Ring Segments
    • 3.1.5 Refractive Surgery
      • 3.1.5.1 LASIK
      • 3.1.5.2 Custom LASIK (Wavefront-Guided Laser Surgery)
      • 3.1.5.3 Conductive Keratoplasty (CK)
      • 3.1.5.4 Laser Epithelial Keratomileusis (LASEK)
      • 3.1.5.5 PHAKIC IOLs
      • 3.1.5.6 Photorefractive Keratectomy (PRK)
      • 3.1.5.7 Laser Thermal Keratoplasty (LTK)
  • 3.2 Glaucoma Treatment Approaches
    • 3.2.1 Pharmaceutical therapy
    • 3.2.2 Interventional Therapy
  • 3.3 Cornea Diseases and Treatment Options
    • 3.3.1 Allergies
    • 3.3.2 Conjunctivitis (Pink Eye)
    • 3.3.3 Corneal Infections
    • 3.3.4 Dry Eye
    • 3.3.5 Corneal Dystrophies
      • 3.3.5.1 Fuchs' Dystrophy
      • 3.3.5.2 Keratoconus
      • 3.3.5.3 Corneal Transplants
      • 3.3.5.4 Lattice Dystrophy
      • 3.3.5.5 Map-dot-fingerprint Dystrophy
    • 3.3.6 Ocular Herpes
    • 3.3.7 Herpes Zoster (Shingles)
    • 3.3.8 Pterygium
    • 3.3.9 Stevens-Johnson Syndrome
  • 3.4 Cataract Treatment Options
    • 3.4.1 Cataract Surgery
      • 3.4.1.1 Phacoemulsification
      • 3.4.1.2 Hand-held Instruments
      • 3.4.1.3 Intraocular Lenses (IOLs)
  • 3.5 Back of the Eye Disease and Treatment Options
    • 3.5.1 Macular Degeneration
      • 3.5.1.1 Wet and Dry Forms of Macular Degeneration
      • 3.5.1.2 Retinal Detachment
    • 3.5.2 Treatment of Retinal Detachments
      • 3.5.2.1 Laser Photocoagulation
      • 3.5.2.2 Cryopexy
      • 3.5.2.3 Pneumatic Retinopexy
      • 3.5.2.4 Scleral Buckle
      • 3.5.2.5 Pharmaceutical Treatments for Wet AMD

Section 4: Incidence/Prevalence of Ophthalmic Disorders

  • 4.1 Worldwide Incidence and Prevalence of Vision Disorders
    • 4.1.1 The Americas: Vision Disorders
    • 4.1.2 The Americas: Keratoconus
    • 4.1.3 Europe
      • 4.1.3.1 Vision Disorders: Europe
      • 4.1.3.2 Keratoconus: Europe
    • 4.1.4 Asia/Pacific
      • 4.1.4.1 Vision Disorders: Asia/Pacific
      • 4.1.4.2 Keratoconus: Asia/Pacific
    • 4.1.5 Middle East and Africa
      • 4.1.5.1 Vision Disorders: Middle East & Africa
      • 4.1.5.2 Keratoconus: Middle East & Africa
  • 4.2 Worldwide Incidence and Prevalence of Glaucoma
    • 4.2.1 The Americas
    • 4.2.2 Europe
    • 4.2.3 Asia/Pacific
    • 4.2.4 Middle East and Africa
  • 4.3 Cataracts
    • 4.3.1 Cataracts: The Americas
    • 4.3.2 Cataracts: Europe
    • 4.3.3 Cataracts: Asia/Pacific
    • 4.3.4 Cataracts: Middle East & Africa
  • 4.4 Retinal Disease
    • 4.4.1 Retinal Disease: The Americas
    • 4.4.2 Retinal Disease: Europe
    • 4.4.3 Retinal Disease: Asia/Pacific
    • 4.4.4 Retinal Disease: Middle East & Africa

Section 5: THE MARKET FOR OPHTHALMOLOGY PRODUCTS

  • 5.1 Demand for Products and Services
  • 5.2 Global Market for Ophthalmic Products
    • 5.2.1 Refractive Surgery
      • 5.2.1.1 Microkeratomes
      • 5.2.1.2 Flap Cutting Lasers
      • 5.2.1.3 Ablation Lasers
      • 5.2.1.4 Glaucoma
      • 5.2.1.5 Cataract
      • 5.2.1.6 Phacoemusification
      • 5.2.1.7 Hand-held Instruments
    • 5.2.2 Implantable Devices
      • 5.2.2.1 IOLs
      • 5.2.2.2 Back of Eye
  • 5.3 Global Market for Ophthalmic Diagnostic Equipment
    • 5.3.1 Ophthalmic Diagnostic Instrument Market, Americas
      • 5.3.1.1 USA: Ophthalmic Diagnostic Instrument Market
      • 5.3.1.2 USA: Ophthalmic Diagnostic Instrument Market Share (%) by Company
      • 5.3.1.3 Non-USA Americas: Ophthalmic Diagnostic Instrument Market
      • 5.3.1.4 Non-USA Americas: Diagnostic Instrument Market Share (%) by Company
    • 5.3.2 Ophthalmic Diagnostic Instrument Market, Europe
      • 5.3.2.1 UNITED KINGDOM: Ophthalmic Diagnostic Instrument Market
      • 5.3.2.2 UNITED KINGDOM: Ophthalmic Diagnostic Instrument Market Share (%) by Company
      • 5.3.2.3 GERMANY: Ophthalmic Diagnostic Instrument Market
      • 5.3.2.4 GERMANY: Ophthalmic Diagnostic Market Share (%) by Company
      • 5.3.2.5 FRANCE: Ophthalmic Diagnostic Market Share (%) by Company
      • 5.3.2.6 BENELUX: Ophthalmic Diagnostic Instrument Market
      • 5.3.2.7 BENELUX: Ophthalmic Diagnostic Market Share (%) by Company
      • 5.3.2.8 ITALY: Ophthalmic Diagnostic Instrument Market
      • 5.3.2.9 ITALY: Ophthalmic Diagnostic Market Share (%) by Company
      • 5.3.2.10 SPAIN: Ophthalmic Diagnostic Instrument Market
      • 5.3.2.11 SPAIN: Diagnostic Market Share (%) by Company
      • 5.3.2.12 EUROPE: Ophthalmic Diagnostic Instrument Market
    • 5.3.3 Ophthalmic Diagnostic Instrument Market, Asia-Pacific
      • 5.3.3.1 JAPAN: Ophthalmic Diagnostic Instrument Market
      • 5.3.3.2 JAPAN: Ophthalmic Diagnostic Market Share (%) by Company
      • 5.3.3.3 Non-Japan ASIA-PACIFIC: Ophthalmic Diagnostic Instrument Market
      • 5.3.3.4 Non-Japan ASIA-PACIFIC: Ophthalmic Diagnostic Market Share (%) by Company
      • 5.3.3.5 TOTAL Asia Pacific: Ophthalmic Diagnostic Instrument Market
    • 5.3.4 Worldwide: Ophthalmic Diagnostic Instrument Market by Company
  • 5.4 Global Market for Cataract Surgery
    • 5.4.1 Cataract Surgery Market, Americas
      • 5.4.1.1 USA Cataract Surgery Market
      • 5.4.1.2 USA: Cataract Surgery Market Share (%) by Company
      • 5.4.1.3 Non-USA Americas: Cataract Surgery Market
      • 5.4.1.4 Non-USA Americas: Cataract Surgery Market Share (%) by Company
      • 5.4.1.5 AMERICAS: Total Cataract Surgery Market ($Millions) by Company
    • 5.4.2 Cataract Surgery Market, Europe
      • 5.4.2.1 UNITED KINGDOM: Cataract Surgery Market
      • 5.4.2.2 UNITED KINGDOM: Cataract Surgery Market Share (%) by Company
      • 5.4.2.3 GERMANY: Cataract Surgery Market
      • 5.4.2.4 GERMANY: Cataract Surgery Market Share (%) by Company
      • 5.4.2.5 FRANCE: Cataract Surgery Market
      • 5.4.2.6 FRANCE: Cataract Surgery Market Share (%) by Company
      • 5.4.2.7 BENELUX Cataract Surgery Market
      • 5.4.2.8 BENELUX: Cataract Surgery Market Share (%) by Company
      • 5.4.2.9 ITALY Cataract Surgery Market
      • 5.4.2.10 ITALY: Cataract Surgery Market Share (%) by Company
      • 5.4.2.11 SPAIN Cataract Surgery Market
      • 5.4.2.12 SPAIN: Cataract Surgery Market Share (%) by Company
      • 5.4.2.13 EUROPE, Cataract Surgery Product Revenues By Company
    • 5.4.3 Cataract Surgery Market, Asia-Pacific
      • 5.4.3.1 JAPAN Cataract Surgery Market
      • 5.4.3.2 JAPAN: Cataract Surgery Market Share (%) by Company
      • 5.4.3.3 Non-Japan ASIA-PACIFIC: Cataract Surgery Market
      • 5.4.3.4 Non-Japan ASIA-PACIFIC: Cataract Surgery Market Share (%) by Company
      • 5.4.3.5 TOTAL Asia Pacific: Cataract Surgery Market Revenues ($Millions US) by Company
    • 5.4.4 Worldwide: Cataract Surgery Market by Company
  • 5.5 Global Market for Refractive Surgery
    • 5.5.1 Refractive Surgery Market, Americas
      • 5.5.1.1 U.S. Refractive Surgery Market
      • 5.5.1.2 U.S. Refractive Surgery Market Share (%) by Company
      • 5.5.1.3 Non-USA Americas: Refractive Surgery Market
      • 5.5.1.4 Non-USA Americas: Refractive Surgery Market Share (%) by Company
      • 5.5.1.5 AMERICAS: Total Refractive Surgery Revenues by Company
    • 5.5.2 Refractive Surgery Market, Europe
      • 5.5.2.1 UNITED KINGDOM: Refractive Surgery Market
      • 5.5.2.2 UNITED KINGDOM: Refractive Surgery Market Share (%) by Company
      • 5.5.2.3 GERMANY: Refractive Surgery Market
      • 5.5.2.4 GERMANY: Refractive Surgery Market Share (%) by Company
      • 5.5.2.5 FRANCE: Refractive Surgery Market
      • 5.5.2.6 FRANCE: Refractive Surgery Market Share (%) by Company
      • 5.5.2.7 BENELUX: Refractive Surgery Market
      • 5.5.2.8 BENELUX: Refractive Surgery Market Share (%) by Company
      • 5.5.2.9 ITALY: Refractive Surgery Market
      • 5.5.2.10 ITALY: Refractive Surgery Market Share (%) by Company
      • 5.5.2.11 SPAIN: Refractive Surgery Market
      • 5.5.2.12 SPAIN: Refractive Surgery Market Share (%) by Company
      • 5.5.2.13 EUROPE: Refractive Surgery Market by Company
    • 5.5.3 Refractive Surgery Market, Asia-Pacific
      • 5.5.3.1 JAPAN: Refractive Surgery Market by Company
      • 5.5.3.2 JAPAN: Refractive Market Share (%) by Company
      • 5.5.3.3 Non-Japan ASIA-PACIFIC: Refractive Surgery Market by Country
      • 5.5.3.4 Non-Japan ASIA-PACIFIC: Refractive Market Share (%) by Company
      • 5.5.3.5 TOTAL Asia Pacific: Refractive Market by Company
    • 5.5.4 Worldwide: Refractive Surgery Market by Company
  • 5.6 Global Market for Ophthalmic Pharmaceuticals
    • 5.6.1 Ophthalmic Pharmaceuticals Market, Americas
      • 5.6.1.1 U.S. Ophthalmic Pharmaceutical Market
      • 5.6.1.2 U.S. Ophthalmic Pharmaceutical Market Share (%) by Company
      • 5.6.1.3 U.S. Ophthalmic Pharmaceutical Market by Segment
      • 5.6.1.4 Non-USA Americas: Ophthalmic Pharmaceutical Market
      • 5.6.1.5 Non-USA Americas: Ophthalmic Pharmaceutical Market Share (%) by Company
      • 5.6.1.6 Non-USA Americas: Ophthalmic Pharmaceutical Market by Segment
      • 5.6.1.7 AMERICAS: Ophthalmic Pharmaceutical Market by Segment
    • 5.6.2 Ophthalmic Pharmaceuticals Market, Europe
      • 5.6.2.1 UNITED KINGDOM: Ophthalmic Pharmaceutical Market
      • 5.6.2.2 UNITED KINGDOM: Ophthalmic Pharmaceutical Market Share (%) by Company
      • 5.6.2.3 GERMANY: Ophthalmic Pharmaceutical Market
      • 5.6.2.4 GERMANY: Ophthalmic Pharmaceutical Market Share (%) by Company
      • 5.6.2.5 FRANCE: Ophthalmic Diagnostic Instrument Market
      • 5.6.2.6 FRANCE: Ophthalmic Pharmaceutical Market
      • 5.6.2.7 FRANCE: Ophthalmic Pharmaceutical Market Share (%) by Company
      • 5.6.2.8 BENELUX: Ophthalmic Pharmaceutical Market
      • 5.6.2.9 BENELUX: Ophthalmic Pharmaceutical Market Share (%) by Company
      • 5.6.2.10 ITALY: Ophthalmic Pharmaceutical Market
      • 5.6.2.11 ITALY: Ophthalmic Pharmaceutical Market Share (%) by Company
      • 5.6.2.12 SPAIN: Ophthalmic Pharmaceutical Market
      • 5.6.2.13 SPAIN: Ophthalmic Pharmaceutical Market Share (%) by Company
      • 5.6.2.14 EUROPE: Ophthalmic Pharmaceutical Market by Company
      • 5.6.2.15 EUROPE: Ophthalmic Pharmaceutical Market by Segment
    • 5.6.3 Ophthalmic Pharmaceuticals Market, Asia-Pacific
      • 5.6.3.1 JAPAN: Ophthalmic Pharmaceutical Market by Company
      • 5.6.3.2 JAPAN: Ophthalmic Pharmaceutical Market Share (%) by Company
      • 5.6.3.3 Non-Japan ASIA-PACIFIC: Ophthalmic Pharmaceutical Market by Company
      • 5.6.3.4 Non-Japan ASIA-PACIFIC: Ophthalmic Pharmaceutical Market Share (%) by Company
      • 5.6.3.5 TOTAL Asia Pacific: Ophthalmic Pharmaceutical Market by Company
      • 5.6.3.6 TOTAL Asia Pacific: Ophthalmic Pharmaceutical Market by Segment
    • 5.6.4 Worldwide: Ophthalmic Pharmaceutical Market
      • 5.6.4.1 Worldwide: Ophthalmic Pharmaceutical Market by Company
      • 5.6.4.2 Worldwide: Ophthalmic Pharmaceutical Market by Segment

Section 6: Company Profiles

  • 6.1 Leading Companies
    • 6.1.1 Advanced Medical Optics
      • 6.1.1.1 Overview
      • 6.1.1.2 Products
      • 6.1.1.3 Pipeline
      • 6.1.1.4 Financials
    • 6.1.2 Alcon Laboratories, Inc.
      • 6.1.2.1 Overview
    • 6.1.3 Allergan
      • 6.1.3.1 Overview
      • 6.1.3.2 Products
      • 6.1.3.3 Pipeline
      • 6.1.3.4 Financials
    • 6.1.4 Bausch & Lomb
      • 6.1.4.1 Overview
      • 6.1.4.2 Products
      • 6.1.4.3 Pipeline
      • 6.1.4.4 Financials
    • 6.1.5 Carl Zeiss Meditech
      • 6.1.5.1 Overview
      • 6.1.5.2 Products
      • 6.1.5.3 Pipeline
      • 6.1.5.4 Financials
    • 6.1.6 IntraLase, Inc.
      • 6.1.6.1 Overview
      • 6.1.6.2 Products
      • 6.1.6.3 Pipeline
      • 6.1.6.4 Financials
    • 6.1.7 STAAR Surgical
      • 6.1.7.1 Overview
      • 6.1.7.2 Products
      • 6.1.7.3 Pipeline
      • 6.1.7.4 Financials
    • 6.1.8 Iridex Corporation
      • 6.1.8.1 Overview
      • 6.1.8.2 Products
      • 6.1.8.3 Pipeline
      • 6.1.8.4 Financials
  • 6.2 Other Companies
    • 6.2.1 Acufocus
    • 6.2.2 Addition Technology, Inc.
    • 6.2.3 Advanced Cell Tech, Inc.
    • 6.2.4 American Optisurgical, Inc. (AOI)
    • 6.2.5 Aquasys, Inc
    • 6.2.6 BD Medical Ophthalmic
    • 6.2.7 Biosyntrx, Inc.
    • 6.2.8 Calhoun Vision
    • 6.2.9 CustomVis
    • 6.2.10 Eagle Vision
    • 6.2.11 Eli Lilly
    • 6.2.12 Endo Optiks, Inc.
    • 6.2.13 Escalon Medical Imaging
    • 6.2.14 EyeKon Medical
    • 6.2.15 Eyemaginations
    • 6.2.16 Eyeonics, Inc.
    • 6.2.17 EyeSys Vision, Inc.
    • 6.2.18 FCI Ophthalmics
    • 6.2.19 Genentech
    • 6.2.20 Geuder AG
    • 6.2.21 Glaukos
    • 6.2.22 Haag-Streit
    • 6.2.23 Heidelberg Engineering, Inc.
    • 6.2.24 Heine
    • 6.2.25 Howard Instruments
    • 6.2.26 Huvitz
    • 6.2.27 IOP, Inc.
    • 6.2.28 IRIDEX
    • 6.2.29 iScience Interventional
    • 6.2.30 ISTA Pharmaceuticals
    • 6.2.31 Keeler Instruments
    • 6.2.32 Kowa Optimed
    • 6.2.33 Lacrimedics
    • 6.2.34 Leica Microsystems
    • 6.2.35 Lenstec Inc
    • 6.2.36 Lumenis
    • 6.2.37 MacuScope
    • 6.2.38 MacuSight, Inc.
    • 6.2.39 Marco
    • 6.2.40 Mastel Precision
    • 6.2.41 Medennium
    • 6.2.42 Micro Medical Devices, Inc
    • 6.2.43 Moeller-Wedel.
    • 6.2.44 MST
    • 6.2.45 Neitz Instruments Co
    • 6.2.46 NeoMedix
    • 6.2.47 NeoVista
    • 6.2.48 New World Medical
    • 6.2.49 Nidek, Inc.
    • 6.2.50 Novadaq Technologies
    • 6.2.51 Novartis Ophthalmics
    • 6.2.52 NovaVision Inc.
    • 6.2.53 OASIS Medical
    • 6.2.54 OccuLogix
    • 6.2.55 OculusGen Biomedical
    • 6.2.56 Odyssey Medical
    • 6.2.57 Omni Lens
    • 6.2.58 Ophtec
    • 6.2.59 Optikon 2000 s.p.a.
    • 6.2.60 Optimedica
    • 6.2.61 Optos, Inc.
    • 6.2.62 Optovue.
    • 6.2.63 Pelion Surgical
    • 6.2.64 Pfizer Ophthalmics
    • 6.2.65 Quest Medical
    • 6.2.66 Refractec
    • 6.2.67 Reichert
    • 6.2.68 Regeneron Pharmaceuticals
    • 6.2.69 Rhein Medical
    • 6.2.70 Santen, Inc.
    • 6.2.71 Scan Optics
    • 6.2.72 Schwind Eye-tech Solutions
    • 6.2.73 ScyFIX
    • 6.2.74 Second Sight
    • 6.2.75 Sirion Holdings, Inc. (formerly Sirion Therapeutics)
    • 6.2.76 Sonogage
    • 6.2.77 Sonomed.
    • 6.2.78 Stereo Optical Company, Inc.
    • 6.2.79 STAAR Surgical
    • 6.2.80 Surmodics
    • 6.2.81 Synemed
    • 6.2.82 Tekia
    • 6.2.83 Titan Surgical
    • 6.2.84 Tomey
    • 6.2.85 Topcon Medical Systems (TMS)
    • 6.2.86 Tracey Technologies
    • 6.2.87 Trevi Technology
    • 6.2.88 Visiogen, Inc.
    • 6.2.89 Vistakon
    • 6.2.90 Vistakon Pharmaceuticals, LLC
    • 6.2.91 Visual Pathways
    • 6.2.92 WaveLight AG
    • 6.2.93 Welch Allyn
    • 6.2.94 Woodlyn, Inc.
    • 6.2.95 Ziemer Ophthalmic Systems AG.

Appendix: Company Addresses

  • APPENDIX A: Worldwide Prevalence of Vision Disorders
  • APPENDIX B: Worldwide Prevalence of Keratoconus
  • APPENDIX C: Worldwide Prevalence of Glaucoma
  • APPENDIX D: Worldwide Prevalence of Cataracts
  • APPENDIX E: Worldwide Prevalence of Back of Eye Disorders
  • Exhibit ES-1: Total Ophthalmic Products Market by Segment, 2006
  • Exhibit ES-2: Ophthalmic Product Revenues (Diagnostics, Surgical, Pharmaceuticals) by Country/Region
  • Exhibit 1-1: Optometrist Practice by Type
  • Exhibit 1-2: Ophthalmologists by Sub-Specialty
  • Exhibit 1-3: Practicing Ophthalmologists by Type of Practice/Role
  • Exhibit 1-4: Ophthalmologists by Practice Type
  • Exhibit 1-5: Cross-Sectional Schematic of the Human Eye
  • Exhibit 1-6: Snellen Eye Chart
  • Exhibit 2-1: Hand-Held Instrument Category Offerings, by Manufacturer
  • Exhibit 2-2: Diagnostic Equipment Used by the Eye Care Professional and Average Selling Prices
  • Exhibit 2-3: Worldwide Diagnostic Instrumentation Revenue, U.S. and Non-U.S., by Segment, 2006
  • Exhibit 2-4: Diagnostic Instrumentation Offerings, By Manufacturer
  • Exhibit 2-5: Percent of Ophthalmic Diagnostic Equipment Sold to O.D. vs M.D. in US vs International (OUS) Markets
  • Exhibit 3-1: Manufacturers of Corneal Reshaping Lenses
  • Exhibit 3-2: Manufacturers of Implantable Corneal Ring Segment Products for Vision Correction
  • Exhibit 3-3: LASIK Products and Manufacturers
  • Exhibit 3-4: Products Used in Custom Ablation LASIK
  • Exhibit 3-5: Phakic IOL Manufacturers and Products
  • Exhibit 3-6: Products for Non-LASIK Refractive Surgery Procedures
  • Exhibit 3-7: Open-Angle Glaucoma Prevalence Rates by Age and Race
  • Exhibit 3-8: Share of U.S. Glaucoma Medication Sales by Type, 2005
  • Exhibit 3-9: Glaucoma Pharmaceutical Products
  • Exhibit 3-10: Medical Device Products for the Treatment of Glaucoma
  • Exhibit 3-11: U.S. Glaucoma Treatment Procedures by Type, 2006
  • Exhibit 3-12: Pharmaceutical Allergy Medications
  • Exhibit 3-13: Anti-Infective and Anti-Inflammatory Ophthalmic Pharmaceutical Products
  • Exhibit 3-14: Products for the Treatment of Dry Eye
  • Exhibit 3-15: Ophthalmic Drugs by Type, 2004 & 2008
  • Exhibit 3-16: Phacoemulsification Systems for Cataract Surgery, U.S. and Rest of World, 2006
  • Exhibit 3-17: Phacoemulsification Equipment and Accessories
  • Exhibit 3-18: Conventional Intraocular Lens Manufacturers and Products
  • Exhibit 3-19: IOL Accessory Manufacturers and Products
  • Exhibit 3-20: Cataract Surgery Procedures, U.S. and Worldwide, 2003-2008
  • Exhibit 3-21: Multifocal IOL Manufacturers and Products
  • Exhibit 3-22: Phakic IOL Products and Manufacturers
  • Exhibit 3-23: Pharmaceuticals to Treat Age-related Macular Degeneration
  • Exhibit 3-24: Alternatives to Pharmaceutical Developments for the Treatment of Wet AMD
  • Exhibit 3-25: Manufacturers of Equipment for the Treatment of Retinal Disorders
  • Exhibit 4-1: The Americas, Prevalence of Vision Disorders
  • Exhibit 4-2: The Americas, Prevalence of Keratoconus
  • Exhibit 4-3: Europe, Prevalence of Vision Disorders
  • Exhibit 4-4: Europe, Prevalence of Keratoconus, by Country
  • Exhibit 4-5: Asia-Pacific, Prevalence of Vision Disorders
  • Exhibit 4-6: Asia-Pacific, Prevalence of Keratoconus
  • Exhibit 4-7: Middle East & Africa, Prevalence of Vision Disorders
  • Exhibit 4-8: Middle East & Africa, Prevalence of Keratoconus
  • Exhibit 4-9: U.S., Glaucoma Prevalence by Age
  • Exhibit 4-10: The Americas, Prevalence of Diagnosed and Undiagnosed Glaucoma, by Country
  • Exhibit 4-11: Europe, Glaucoma Prevalence, by Country
  • Exhibit 4-12: Asia-Pacific, Glaucoma Prevalence, by Country
  • Exhibit 4-13: Middle East & Africa, Glaucoma Prevalence, by Country
  • Exhibit 4-14: The Americas, Cataract Prevalence by Age
  • Exhibit 4-15: The Americas, Cataract Prevalence, by Country
  • Exhibit 4-16: Europe, Cataract Prevalence, by Country
  • Exhibit 4-17: Asia-Pacific, Cataract Prevalence, by Country
  • Exhibit 4-18: Middle East & Africa, Cataract Prevalence, by Country
  • Exhibit 4-19: The America, Prevalence of Diabetic Retinopathy Among Adults
  • Exhibit 4-20: The Americas, Age-Related Macular Degeneration Prevalence by Age and Type
  • Exhibit 4-21: Europe, Prevalence of Retinal Disease, by Country
  • Exhibit 4-22: Asia-Pacific, Prevalence of Retinal Disease, by Country
  • Exhibit 4-23: Middle East & Africa, Prevalence of Retinal Disease, by Country
  • Exhibit 5-1: Healthcare Expenditure by Country
  • Exhibit 5-2: Worldwide Ophthalmic Products Market by Segment, 2006
  • Exhibit 5-3: Percentage of Refractive Surgery Procedures by Type, Worldwide, 2004-2010
  • Exhibit 5-4: Manufacturers and Product Offerings in Refractive Surgery
  • Exhibit 5-5: Shares of Flap-Cutting Procedure Market by Company, 2005 & 2010
  • Exhibit 5-6: Ophthalmic Pharmaceutical Revenues, by Type, 2008
  • Exhibit 5-7: U.S. Glaucoma Procdures by Type, 2005
  • Exhibit 5-8: Phacoemulsification Systems for Cataract Surgery, U.S. and ROW, 2005
  • Exhibit 5-9: Worldwide Cataract Surgery Market by Product Segment: IOLs, Phaco Equipment and Viscoelastics, 2003-2008
  • Exhibit 5-10: USA: Diagnostic Instrument Market, 2004-2012
  • Exhibit 5-11: U.S. Diagnostic Instrument Market Share by Company, 2004-2012
  • Exhibit 5-12: Non-USA Americas, Diagnostic Instrument Market, 2004-2012
  • Exhibit 5-13: Non-USA Americas: Diagnostic Instrument Market Share by Company
  • Exhibit 5-14: United Kingdom, Diagnostic Instrument Market, 2004-2012
  • Exhibit 5-15: United Kingdom, Ophthalmic Diagnostic Instrument Market Share by Company, 2004-2012
  • Exhibit 5-16: Germany, Diagnostic Instrument Market, 2004-2012
  • Exhibit 5-17: Germany, Diagnostic Market Share by Company, 2004-2012
  • Exhibit 5-18: France, Ophthalmic Diagnostic Market Share by Company, 2004-2012
  • Exhibit 5-19: BeNeLux, Ophthalmic Diagnostic Instrument Market, 2004-2012
  • Exhibit 5-20: BeNeLux, Diagnostic Market Share by Company, 2004-2012
  • Exhibit 5-21: Italy, Diagnostic Instrument Market, 2004-2012
  • Exhibit 5-22: Italy, Diagnostic Market Share by Company, 2004-2012
  • Exhibit 5-23: Spain, Diagnostic Instrument Market, 2004-2012
  • Exhibit 5-24: Spain, Diagnostic Market Share by Company, 2004-2012
  • Exhibit 5-25: Europe, Diagnostic Instrument Market, 2004-2012
  • Exhibit 5-26: Japan, Diagnostic Instrument Market, 2004-2012
  • Exhibit 5-27: Japan, Diagnostic Market Share (%) by Company, 2004-2012
  • Exhibit 5-28: Non-Japan Asia-Pacific, Ophthalmic Diagnostic Instrument Market, 2004-2012
  • Exhibit 5-29: Non-Japan Asia-Pacific, Diagnostic Market Share by Company, 2004-2012
  • Exhibit 5-30: Total Asia Pacific, Diagnostic Instrument Market ($000s), 2004-2012
  • Exhibit 5-31: Worldwide Ophthalmic Diagnostic Instrument Market ($000s) by Company, 2004-2012
  • Exhibit 5-32: USA Cataract Surgery Market, 2004-2012
  • Exhibit 5-33: U.S. Cataract Surgery Market Share by Company, 2004-2012
  • Exhibit 5-34: Non-USA Americas, Cataract Surgery Market, 2004-2012
  • Exhibit 5-35: Non-USA Americas: Cataract Surgery Market Share (%) by Company, 2004-2012
  • Exhibit 5-36: Americas, Total Cataract Surgery Market by Company, 2004-2012
  • Exhibit 5-37: Total Americas Cataract Surgery Market, 2004-2012
  • Exhibit 5-38: United Kingdom, Cataract Surgery Market, 2004-2012
  • Exhibit 5-39: United Kingdom, Cataract Surgery Market Share by Company, 2004-2012
  • Exhibit 5-40: Germany Cataract Surgery Market, 2004-2012
  • Exhibit 5-41: Germany, Cataract Surgery Market Share by Company
  • Exhibit 5-42: France, Cataract Surgery Market, 2004-2012
  • Exhibit 5-43: France, Cataract Surgery Market Share by Company, 2004-2012
  • Exhibit 5-44: BeNeLux, Cataract Surgery Market, 2004-2012
  • Exhibit 5-45: BeNeLux, Cataract Surgery Market Share by Company, 2004-2012
  • Exhibit 5-46: Italy, Cataract Surgery Market, 2004-2012
  • Exhibit 5-47: Italy, Cataract Surgery Market Share by Company, 2004-2012
  • Exhibit 5-48: Spain, Cataract Surgery Market, 2004-2012
  • Exhibit 5-49: Spain, Cataract Surgery Market Share by Company, 2004-2012
  • Exhibit 5-50: Europe, Cataract Surgery Product Revenues by Company, 2004-2012
  • Exhibit 5-51: European Revenue Trends for Cataract Surgery Companies, 2004-2012
  • Exhibit 5-52: Japan, Cataract Surgery Market, 2004-2012
  • Exhibit 5-53: Japan, Cataract Surgery Market Share by Company, 2004-2012
  • Exhibit 5-54: Non-Japan Asia-Pacific, Cataract Surgery Market, 2004-2012
  • Exhibit 5-55: Non-Japan Asia-Pacific, Cataract Surgery Market Share by Company, 2004-2012
  • Exhibit 5-56: Total Asia-Pacific, Cataract Surgery Market Revenues by Company, 2004-2012
  • Exhibit 5-57: Worldwide Cataract Surgery Market by Company, 2004-2012
  • Exhibit 5-58: U.S. Refractive Surgery Market, 2004-2012
  • Exhibit 5-59: U.S. Refractive Surgery Market Share (%) by Company, 2004-2012
  • Exhibit 5-60: Non-USA Americas, Refractive Surgery Market, 2004-2012
  • Exhibit 5-61: Non-USA Americas, Refractive Surgery Market Share by Company, 2004-2012
  • Exhibit 5-62: Americas, Total Refractive Surgery Revenues ($000s), by Company, 2004-2012
  • Exhibit 5-63: United Kingdom, Refractive Surgery Market, 2004-2012
  • Exhibit 5-64: United Kingdom, Refractive Surgery Market Share by Company, 2004-2012
  • Exhibit 5-65: Germany, Refractive Surgery Market, 2004-2012
  • Exhibit 5-66: Germany, Refractive Surgery Market Share by Company, 2004-2012
  • Exhibit 5-67: France, Refractive Surgery Market, 2004-2012
  • Exhibit 5-68: France, Refractive Surgery Market Share by Company, 2004-2012
  • Exhibit 5-69: BeNeLux, Refractive Surgery Market, 2004-2012
  • Exhibit 5-70: BeNeLux, Refractive Surgery Market Share by Company, 2004-2012
  • Exhibit 5-71: Italy, Refractive Surgery Market, 2004-2012
  • Exhibit 5-72: Italy, Refractive Surgery Market Share by Company, 2004-2012
  • Exhibit 5-73: Spain, Refractive Surgery Market, 2004-2012
  • Exhibit 5-74: Spain, Refractive Surgery Market Share by Company, 2004-2012
  • Exhibit 5-75: Europe, Refractive Surgery Market by Company, 2004-2012
  • Exhibit 5-76: Japan, Refractive Surgery Market by Company, 2004-2012
  • Exhibit 5-77: Japan, Refractive Market Share by Company, 2004-2012
  • Exhibit 5-78: Non-Japan Asia-Pacific, Refractive Surgery Market by Country
  • Exhibit 5-79: Non-Japan Asia-Pacific, Refractive Surgery Market by Company
  • Exhibit 5-80: Total Asia Pacific Refractive Market by Company, 2004-2012
  • Exhibit 5-81: Worldwide Refractive Surgery Market by Company, 2004-2012
  • Exhibit 5-82: Leading Suppliers of Dry Eye Products and Annual Dry Eye Product Sales
  • Exhibit 5-83: Worldwide Ophthalmic Pharmaceutical Sales by Supplier
  • Exhibit 5-84: U.S. Ophthalmic Drug Revenue Shares by Supplier, 2003-2010
  • Exhibit 5-85: U.S. Ophthalmic Pharmaceutical Market, 2004-2012
  • Exhibit 5-86: U.S. Ophthalmic Pharmaceutical Market Share) by Company, 2004-2012
  • Exhibit 5-87: U.S. Ophthalmic Pharmaceutical Market by Segment, 2004-2012
  • Exhibit 5-88: Non-USA Americas, Ophthalmic Pharmaceutical Market, 2004-2012
  • Exhibit 5-89: Non-USA Americas, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012
  • Exhibit 5-90: Non-USA Americas, Ophthalmic Pharmaceutical Market by Segment, 2004-2012
  • Exhibit 5-91: Total Americas, Ophthalmic Pharmaceutical Market by Segment, 2004-2012
  • Exhibit 5-92: United Kingdom, Ophthalmic Pharmaceutical Market, 2004-2012
  • Exhibit 5-93: United Kingdom, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012
  • Exhibit 5-94: Germany, Ophthalmic Pharmaceutical Market, 2004-2012
  • Exhibit 5-95: Germany, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012
  • Exhibit 5-96: France, Diagnostic Instrument Market, 2004-2012
  • Exhibit 5-97: France, Ophthalmic Pharmaceutical Market, 2004-2012
  • Exhibit 5-98: France, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012
  • Exhibit 5-99: BeNeLux, Ophthalmic Pharmaceutical Market, 2004-2012
  • Exhibit 5-100: BeNeLux, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012
  • Exhibit 5-101: Italy, Ophthalmic Pharmaceutical Market, 2004-2012
  • Exhibit 5-102: Italy, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012
  • Exhibit 5-103: Spain, Ophthalmic Pharmaceutical Market, 2004-2012
  • Exhibit 5-104: Spain, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012
  • Exhibit 5-105: Europe, Ophthalmic Pharmaceutical Market by Company, 2004-2012
  • Exhibit 5-106: Europe, Ophthalmic Pharmaceutical Market by Segment, 2004-2012
  • Exhibit 5-107: Japan, Ophthalmic Pharmaceutical Market, 2004-2012
  • Exhibit 5-108: Japan, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012
  • Exhibit 5-109: Non-Japan Asia-Pacific, Ophthalmic Pharmaceutical Market, 2004-2012
  • Exhibit 5-110: Non-Japan, Asia-Pacific, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012
  • Exhibit 5-111: Total Asia-Pacific Ophthalmic Pharmaceutical Market ($000s) by Company, 2004-2012
  • Exhibit 5-112: Total Asia-Pacific Ophthalmic Pharmaceutical Market by Segment, 2004-2012
  • Exhibit 5-113: Worldwide Ophthalmic Pharmaceutical Market ($millions) by Company, 2004-2012
  • Exhibit 5-114: Worldwide Ophthalmic Pharmaceutical Market ($000s) by Segment, 2004-2012
  • Exhibit 6-1: Recent Acquisitions Contributing to the AMO Product Line
  • Exhibit 6-2: AMO Cataract and Refractive Surgical Brands
  • Exhibit 6-3: AMO 2005 Revenues by World Region and Product Category ($000s)
  • Exhibit 6-4: Projected 2006 AMO Sales by Product Line
  • Exhibit 6-5: Alcon Pharmaceutical & Surgical Products
  • Exhibit 6-6: Alcon Product Launches Adding to International Pipeline
  • Exhibit 6-7: Alcon Revenue (Millions), 2003-2006
  • Exhibit 6-8: 2005 Alcon Revenues by World Region and Product Category ($000s)
  • Exhibit 6-9: Alcon Projected 2006 Sales by Product Line
  • Exhibit 6-10: Allergan Pharmaceutical Products by Category
  • Exhibit 6-11: Net Sales of Allergan Specialty Pharmaceutical Products, 2003-2005
  • Exhibit 6-12: Net Allergan Sales by Geographic Region, 2003-2005
  • Exhibit 6-13: Bausch & Lomb 2006 Product Mix by Percentage of Revneues
  • Exhibit 6-14: B&L Product Brands by Category
  • Exhibit 6-15: B&L Sales Estimates for 2005 and 2006 by Geographic Region
  • Exhibit 6-16: The new Carl Zeiss Meditec after CZSurgical acquisition
  • Exhibit 6-17: Breakdown of Carl Zeiss Meditec' s Business by Revenue and Business Segment
  • Exhibit 6-18: Carl Zeiss Meditech Consolidated Sales by Region for FY 2005/2006E
  • Exhibit 6-19: IntraLase Revenues by Product and Year
  • Exhibit 6-20: IntraLase Revenues by Geographic Region, 2003-2006
  • Exhibit 6-21: STAAR Surgical Sales, 2003-2006
  • Exhibit 6-22: STAAR Revenues by Product Category, 2006
  • Exhibit 6-23: IRIDEX Ophthalmology Revenues by Geography, 2003-2006
  • Exhibit 6-24: Growth of IRIDEX International Market Sales, 2003-2006
Related Report
Ophthalmic Lasers Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and Corrective Vision, 2nd Ediiton Intra Ocular Lenses Pipeline Technology and Market Forecasts to 2015 The U.S. Eyewear Market: Prescription and Nonprescription Lenses, Sunglasses, Contact Lenses, and Frames, 2nd Edition U.S. Market for Diagnostic Ophthalmic Devices 2009
Back to Top
Please inform me when related publications are released
InfoWatch

| FAQ | About The Infoshop | Policies | Site Map |
US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.